Past Agendas

2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004

The Twitter hashtag for the 2019 event is #CVFORUM19. Request an invite if you are interested in joining us for the 2019 conference.

2019 Agenda


Wednesday, May 8th

4:00pm - 6:00pm
Pre-event Session Hosted by STAT+ | 28 Atlantic: Private Dining Room
The New Biology of Healthy Aging: Can Killing Your Old Cells Keep You Young?
Nathaniel David, Co-founder and President, Unity Biotechnology
Interviewer: Matthew Herper, Senior Medicine Writer, STAT
This session is open to all participants but seating is limited so pre-registration is required.

Thursday, May 9th

8:00am – 4:45pm
Registration | Pavilion Reception

8:00am –9:30am
Networking Breakfast | Garden Terrace

9:30am –10:00am
Welcome & Participant introductions | Pavilion

10:00am –10:45am | Pavilion
Frontier Science
Ed Boyden, PhD, Associate Professor of Media Arts and Sciences and Y. Eva Tan Professor in Neurotechnology, MIT Media Lab and the MIT McGovern Institute

10:45am –11:15am
Networking Break

11:15am –12:00pm | Pavilion
Marijuana: Miracle or Myth?

Speaker: Ryan Ansin, Co-founder, Revolutionary Farms
Speaker: Staci Gruber, PhD, Director, Marijuana Investigations for Neuroscientific Discovery (MIND) Program, McLean Hospital
Moderator: Gabor Garai, Partner, Foley & Lardner

12:00pm –1:30pm | Garden Terrace
Lunch & Lunch Conversations

12:00pm –1:30pm | 28 Atlantic: Private Dining Room
Lunch Discussion: The Critical Hires as Your Program Gets off the Ground: Chief Development Officer or Chief Medical Officer?

Speaker: Tom Hughes, PhD, CEO, Navitor Pharmaceuticals
Speaker: Gilmore O’Neill, MB, MMSc, Chief Medical Officer, Sarepta Therapeutics
Moderator: Laurie Halloran, President & CEO, Halloran Consulting

1:30pm –2:00pm | Pavilion
A Look at R&D and Business Development at Eli Lilly
Daniel Skrovronsky, MD, PhD, SVP and Chief Scientific Officer, Eli Lilly & Company

2:00pm –2:15pm
Networking Break

2:15pm –3:15pm | Pavilion
Breakout Session A: A Look at Three Startups in Stealth

Speaker: Adam Friedman, MD, PhD, Founder, President & CEO, Vivid Biosciences, LLC
Speaker: Baruch Harris, PhD, Chief Operating Officer, Metera Pharmaceuticals, Inc. 
Speaker: James Rosen, CEO, Artizan Biosciences
Moderator: Marian Nakada, PhD, VP of Venture Investments, JJDC

2:15pm –3:15pm | Pavilion
Breakout Session B: Partnerships: What Makes Them Successful from the Start

Speaker: Mike Cloonan, Chief Business Officer, Sage Therapeutics
Speaker: Liz Leveille, Associate Vice President and Head, Boston Innovation Hub, BD&L, Merck
Moderator: Anna Protopapas, President and CEO, Mersana Therapeutics

2:15pm –3:15pm | Pavilion
Breakout Session C: CFIUS and Other VC Deal Dynamics at Play in 2019
Bart Dzikowski, Head of Transactions & Legal, Novartis Venture Fund
Mark Engel, CEO, Phagelux
Jamie Heywood, Co-Founder & Chief Research Officer, iCarbonX
Moderator: Steve Dickman, CEO, CBT Advisors

3:15pm –3:30pm
Networking Break

3:30pm –4:15pm | Pavilion
True Stories from the Road to IPO (and Afterwards)
Pablo Cagnoni, MD, CEO, Rubius Therapeutics
Speaker: Jason Gardner, PhD, CEO, Magenta Therapeutics
Speaker: Paula Soteropoulos, CEO, Akcea Therapeutics
Moderator: Matthew Herper, Senior Writer, Medicine, and Editorial Director, Events, Stat

4:45pm –6:15pm | 28 Atlantic: Private Dining Room
Sign Up on-site required, limited space
Wine Tasting: Hosted by UBS

4:45pm –6:45pm | Sign Up on-site required, limited space in each
Bay Cruise | Golf Workshop |
 Chocolate Tasting & Truffle Making

7:00pm –9:30pm | Outer bar

FRIDAY, May 10th

8:00am – 3:00pm
Registration | Pavilion Reception

8:00am – 9:00am
Networking Breakfast | Garden Terrace

9:00am – 9:45am | Pavilion
Leadership Lessons
David Meeker, MD, CEO, KSQ Therapeutics
Speaker: John Maraganore, PhD, CEO, Alnylam Pharmaceuticals
Speaker: Kazumi Shiosaki, PhD, President and CEO, Twentyeight-Seven
Moderator: Anne Mostue, Reporter and Anchor, Bloomberg News Radio and Television

9:45am – 10:15am
Networking Break

10:15am – 11:00am | Pavilion
Healthcare: Are We Focusing on All the Wrong Things?
Sandro Galea, MD, MPH, DrPH, Dean and Robert A. Knox Professor, School of Public Health, Boston University
Moderator: Alison Taunton-Rigby, OBE, PhD, Director & Trustee, Healthcare, Life Sciences and Financial Services

11:00am – 11:30am
Networking Break

11:30am – 12:15pm | Pavilion
Digital Therapeutics: What's Possible?

Speaker: Eddie Martucci, PhD, Co-Founder and CEO, Akili Interactive Labs
Speaker: Corey McCann, MD, PhD, Founder and CEO, Pear Therapeutics Inc.
Speaker: Joris van Dam, PhD, Executive Director, Head of Digital Therapeutics, Novartis Institute for BioMedical Research (NIBR)
Moderator: Karen Bernstein, PhD, Co-Founder and Chairman, BioCentury Inc.

12:15pm – 1:30pm | Garden Terrace
Lunch & Lunch Conversations

1:30pm – 2:15pm | Pavilion
The New Focus at Novartis Institutes for BioMedical Research
James Bradner, MD, President, Novartis Institutes for BioMedical Research (NIBR)
Moderator: Matthew Herper, Senior Writer, Medicine, and Editorial Director, Events, STAT News

2:15pm – 2:30pm
Networking Break

2:30pm – 3:15pm | 28 Atlantic: Private Dining Room
Tough Tech: Building Companies Around Risky Technology

Speaker: Paulo Garcia, PhD, Co-Founder and CEO, Kytopen Corp.
Nabiha Saklayen, PhD, CEO and Co-Founder, Cellino
Moderator: Ann DeWitt, PhD, General Partner, The Engine